← All Sponsors
SPONSOR

Fore Biotherapeutics

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Cancer Harboring BRAF AlterationsHGGLGGSolid Tumors
NCT05503797 Phase 2
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Cancer Harboring BRAF Alterations
United States, Australia, Canada View Trial →